Ganfeng Lithium (01772.HK): Ganfeng Lithium Battery Participates in Investment in Limited Partnership with Capital Commitment of RMB 100 Million
NewTimeSpace News: On August 18, 2026, Ganfeng Lithium (01772.HK) issued an overseas regulatory announcement stating that its holding subsidiary, Ganfeng Lithium Battery, together with other partners, formally signed the "Partnership Agreement" on August 18, 2026, to jointly invest in Gongqing City Ganfeng Tiantai Venture Investment Partnership (Limited Partnership). The fund size is RMB 216 million, with Ganfeng Lithium Battery committing RMB 100 million, representing a contribution ratio of 46.2963%, acting as a limited partner.
Ganfeng Lithium stated that this investment is aimed at improving Ganfeng Lithium Battery's industrial layout, mastering cutting-edge technologies, and promoting industrial synergy. The partnership will not be consolidated into the company's financial statements. The source of funds is its own capital, and it will not have a material impact on the company's financial condition or operating results.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Ganfeng Lithium (01772.HK): Shareholder Wang Xiaoshen Pledges 5.7 Million Shares, Cumulative Pledge Ratio Accounts for 46.96% of His Shareholding
- QINGLING MOTORS (01122.HK): Repurchase Deal for 30 NEVs up to RMB 12.6m
- JINTAI ENERGY H (02728.HK): Bai Jie Appointed Chairman of the Board and Nomination Committee; Han Jinfeng Steps Down as Chairman, Remains Executive Director
- GANFENGLITHIUM (01772.HK): VP's reduction plan expires without implementation, holding unchanged at 215,050 shares
- CH BIOTECH SER (08037.HK): Penbo (Hainan) BNCT hospital enters into cross-border oncology cooperation agreement with Hong Kong Oncare